Event
Unitree Robotics Issues Announcement on Abnormal Stock Price Movement and Warns of Risks
3 reports · 3 sources
Unitree Robotics issued an announcement stating that the cumulative deviation of the company's stock closing price increase over three consecutive trading days exceeded 30%, constituting an abnormal fluctuation in stock trading. In the announcement, the company warned that the humanoid robot industry is still in the early stages of commercialization, and that uncertainty exists in technology maturity, cultivation of downstream market demand, and supply chain supporting capabilities; if the progress of large-scale commercialization falls short of expectations, the company's future revenue expansion and performance realization may be adversely affected, and there is an investment risk of valuation regression.
Report timeline
- Unitree Technology's stock rises over 30% in 3 days, then issues announcement on abnormal trading fluctuations
Unitree Technology issued an announcement on abnormal stock trading fluctuations after its closing price deviation accumulated to over 30% across three consecutive trading days on October 16, 19, and 20. It closed at 526.03 yuan per share on October 20, with a market value of 212.8 billion yuan.
电子工程专辑 · 微信公众号 ·
- Unitree Technology issues announcement: urgent risk warning!
Unitree Technology issued a stock trading abnormal fluctuation announcement on the evening of October 20, warning that the cumulative deviation of its stock price over three consecutive trading days exceeded 30%. On October 20, the stock closed at 526.03 yuan per share, with a market value of 212.8 billion yuan and a rolling price-to-earnings ratio of 388.25 times, higher than the industry average of 39.51 times. The company stated that there is no major undisclosed information that should be disclosed and that its operations are normal. The announcement warned that the humanoid robot industry is still in the early commercialization stage, and if large-scale commercialization falls short of expectations, there is an investment risk of valuation regression.
CVer · 微信公众号 ·
- Unitree Robotics: Humanoid Robot Industry Still in Early Commercialization Stage
Unitree Robotics announced that its stock price rose by a cumulative deviation of more than 30% over three consecutive trading days, constituting an abnormal stock trading fluctuation. The company noted that the humanoid robot industry is still in the early commercialization stage, with uncertainty in technology maturity, downstream market demand cultivation, and supply chain support capabilities. If the progress of large-scale commercialization falls short of expectations, revenue expansion and performance realization may be adversely affected, and there is an investment risk of valuation regression.
36Kr Embodied Intelligence ·